1. Home
  2. LGVN vs MDRR Comparison

LGVN vs MDRR Comparison

Compare LGVN & MDRR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LGVN
  • MDRR
  • Stock Information
  • Founded
  • LGVN 2014
  • MDRR 2015
  • Country
  • LGVN United States
  • MDRR United States
  • Employees
  • LGVN N/A
  • MDRR N/A
  • Industry
  • LGVN Medicinal Chemicals and Botanical Products
  • MDRR Real Estate Investment Trusts
  • Sector
  • LGVN Health Care
  • MDRR Real Estate
  • Exchange
  • LGVN Nasdaq
  • MDRR Nasdaq
  • Market Cap
  • LGVN 16.4M
  • MDRR 17.1M
  • IPO Year
  • LGVN 2021
  • MDRR 2018
  • Fundamental
  • Price
  • LGVN $0.77
  • MDRR $14.17
  • Analyst Decision
  • LGVN Strong Buy
  • MDRR
  • Analyst Count
  • LGVN 2
  • MDRR 0
  • Target Price
  • LGVN $6.50
  • MDRR N/A
  • AVG Volume (30 Days)
  • LGVN 410.9K
  • MDRR 7.0K
  • Earning Date
  • LGVN 11-11-2025
  • MDRR 11-11-2025
  • Dividend Yield
  • LGVN N/A
  • MDRR 2.08%
  • EPS Growth
  • LGVN N/A
  • MDRR N/A
  • EPS
  • LGVN N/A
  • MDRR N/A
  • Revenue
  • LGVN $2,073,000.00
  • MDRR $9,649,145.00
  • Revenue This Year
  • LGVN N/A
  • MDRR N/A
  • Revenue Next Year
  • LGVN N/A
  • MDRR N/A
  • P/E Ratio
  • LGVN N/A
  • MDRR N/A
  • Revenue Growth
  • LGVN 68.67
  • MDRR N/A
  • 52 Week Low
  • LGVN $0.63
  • MDRR $9.55
  • 52 Week High
  • LGVN $2.48
  • MDRR $15.00
  • Technical
  • Relative Strength Index (RSI)
  • LGVN 38.17
  • MDRR 59.95
  • Support Level
  • LGVN $0.74
  • MDRR $13.01
  • Resistance Level
  • LGVN $0.85
  • MDRR $14.28
  • Average True Range (ATR)
  • LGVN 0.05
  • MDRR 0.40
  • MACD
  • LGVN 0.02
  • MDRR 0.01
  • Stochastic Oscillator
  • LGVN 34.25
  • MDRR 85.16

About LGVN Longeveron Inc.

Longeveron Inc is a clinical-stage biotechnology company developing regenerative medicines to address unmet medical needs for specific aging-related and life-threatening conditions. Its investigational product is Lomecel-B an stem cell formulation sourced from the bone marrow of young, healthy adult donors and has potential mechanisms of action that can promote tissue repair and healing. The company currently has three pipeline indications: Hypoplastic Left Heart Syndrome (HLHS), Alzheimer's disease (AD) and Aging-related Frailty.

About MDRR Medalist Diversified REIT Inc.

Medalist Diversified REIT Inc is engaged to acquire, reposition, renovate, lease, and manage income-producing properties with a focus on commercial properties, including flex-industrial and retail properties, multi-family residential properties, and hotel properties. The company operates as a UPREIT and owns properties through its subsidiary, Medalist Diversified Holdings, LP. Its reportable segments were retail center properties, flex center properties, and STNL properties.

Share on Social Networks: